Paul Hopper
Executive Chairman
Biopharmaceutical
Imugene
Australia
Biography
Mr. Paul Hopper is Executive Chairman of the Board of Imugene Ltd. He has served as managing director of Cappello Group Inc since November 2005. He brings knowledge of corporate governance issues to the Imugene Board, gained through board positions with a number of ASX listed companies including Viralytics (ASX.VLA) where he is currently Executive Chairman. In the last five years he has been a Director of Somnomed Limited (ASX.SOM), Isonea Limited (ASX.ISN) and Fibrocell Science Inc. He is also currently a Director of pSivida Corp (NASDAQ:PSDV). In over 20 years in international public company markets he has gained experience in life sciences, biotechnology, nutraceuticals, specialty retail, medical & healthcare services and e-commerce.
Research Interest
Biotechnology, nutraceuticals,medical & healthcare.
